Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Ventas’ filings can feel like sorting through hundreds of pages on rent escalators, triple-net lease covenants, and senior-housing occupancy rates. If you’ve ever asked, “Where’s the dividend guidance hidden in Ventas’ annual report 10-K?” or hunted for Ventas insider trading Form 4 transactions, you know the challenge.
Stock Titan solves it. Our platform ingests every Ventas quarterly earnings report 10-Q filing, 8-K, and proxy in real time, then delivers plain-English, AI-powered summaries. Need Ventas Form 4 insider transactions real-time? Get instant alerts. Trying to compare deferred rent trends quarter over quarter? Our AI highlights the numbers and adds context so you’re understanding Ventas SEC documents with AI instead of decoding footnotes.
You’ll find more than a list of forms. We connect each document to what matters for a healthcare REIT: the 10-K section that forecasts SHOP margins, the 8-K paragraph announcing operator restructurings (Ventas 8-K material events explained), or the Ventas proxy statement executive compensation table that details incentive targets. Whether you’re scanning a Ventas annual report 10-K simplified for dividend coverage or running a quick Ventas earnings report filing analysis, the insights are ready in minutes—no spreadsheet gymnastics required. Monitor Ventas executive stock transactions Form 4, track payout ratios, and see AI-generated red-flag alerts across ALL filing types the moment they hit EDGAR.
Reporting person: Robert F. Probst, EVP and CFO of Ventas, Inc. (VTR). Transaction date: 08/04/2025; Form filed: 08/06/2025.
Actions: Probst exercised 29,691 fully vested stock options at an exercise price of $65.45 and sold 29,691 underlying shares pursuant to a Rule 10b5-1 trading plan entered on 02/19/2025. The shares were sold in multiple transactions at prices ranging $68.45–$68.5563 with a weighted average sale price of $68.4917.
Post-transaction position: Beneficial ownership reported as 168,364 shares held directly; 33,591 unexercised options remain (expiration 05/04/2026).
Form 4 Overview: On 07/17/2025, Ventas, Inc. (VTR) director Sumit Roy automatically received two common-stock equivalent grants generated by dividend-equivalent credits: 49.07 units under the Non-Employee Directors’ Cash Compensation Deferral Plan and 78.961 units under the Non-Employee Directors’ Equity Award Deferral Program, totaling 128.031 shares. The grants were valued at the 07/17/2025 closing price of $65.37 and are payable solely in common stock per the respective plan terms.
Following the credits, Roy’s direct beneficial ownership rose to 20,770.297 shares. No open-market transactions, sales, or derivative exercises were reported, and Table II shows no derivative positions. Because the award is routine, non-cash and represents a de-minimis percentage of Ventas’ outstanding shares, it is unlikely to have an immediate impact on share supply or market sentiment.
Form 144 filing: A beneficial owner named Robert F. Probst has notified Ventas, Inc. (VTR) of his intent to sell up to 29,493 common shares through Merrill Private Wealth on the NYSE around 07/21/2025. At the reference price used in the filing, the block is valued at ≈ $1.95 million.
The notice also lists completed sales by the same seller during the last three months: 69,592 shares on 05/21/25, 17,374 shares on 05/27/25, 168,318 shares on 07/14/25, and 4,098 shares on 07/18/25, for combined gross proceeds of ≈ $16.86 million. Adding the proposed sale, the cumulative disposition reaches 288,875 shares.
With Ventas reporting 451.3 million shares outstanding, the new transaction equals roughly 0.0065 % of total shares, implying minimal dilution or market‐moving impact. The standard Rule 144 certification affirms the seller holds no undisclosed material adverse information.
FAQ
What is the current stock price of Ventas (VTR)?
What is the market cap of Ventas (VTR)?
